1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 HIV POC 1.2.3 Clostridium Difficile POC 1.2.4 HBV POC 1.2.5 Respiratory Syncytial Virus POC 1.2.6 HPV POC 1.2.7 Influenza/Flu POC 1.2.8 HCV POC 1.2.9 MRSA POC 1.2.10 TB and Drug-Resistant TB POC 1.3 Market by Application 1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Home 1.3.5 Assisted Living Healthcare Facilities 1.3.6 Laboratories 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2016-2027) 2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Regions 2.2.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021) 2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027) 2.3 Point-of-care Infectious Disease Diagnostics Industry Dynamic 2.3.1 Point-of-care Infectious Disease Diagnostics Market Trends 2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers 2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges 2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue 3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2016-2021) 3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021) 3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue 3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio 3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2020 3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served 3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service 3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type 4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2016-2021) 4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027) 5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application 5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2016-2021) 5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2016-2027) 6.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Type 6.2.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) 6.2.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) 6.2.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027) 6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Application 6.3.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) 6.3.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) 6.3.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027) 6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country 6.4.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) 6.4.2 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2016-2027) 7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type 7.2.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) 7.2.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) 7.2.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027) 7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application 7.3.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) 7.3.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) 7.3.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027) 7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country 7.4.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) 7.4.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2016-2027) 8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type 8.2.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027) 8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application 8.3.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027) 8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region 8.4.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2016-2027) 9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type 9.2.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) 9.2.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) 9.2.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027) 9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application 9.3.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) 9.3.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) 9.3.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027) 9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country 9.4.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) 9.4.2 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2016-2027) 10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type 10.2.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2027) 10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application 10.3.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2027) 10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country 10.4.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction 11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.1.5 Thermo Fisher Scientific Recent Development 11.2 Abbott 11.2.1 Abbott Company Details 11.2.2 Abbott Business Overview 11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction 11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.2.5 Abbott Recent Development 11.3 Calypte Biomedical 11.3.1 Calypte Biomedical Company Details 11.3.2 Calypte Biomedical Business Overview 11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction 11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.3.5 Calypte Biomedical Recent Development 11.4 Chembio Diagnostic Systems 11.4.1 Chembio Diagnostic Systems Company Details 11.4.2 Chembio Diagnostic Systems Business Overview 11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction 11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.4.5 Chembio Diagnostic Systems Recent Development 11.5 Meridian Bioscience 11.5.1 Meridian Bioscience Company Details 11.5.2 Meridian Bioscience Business Overview 11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction 11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.5.5 Meridian Bioscience Recent Development 11.6 MedMira 11.6.1 MedMira Company Details 11.6.2 MedMira Business Overview 11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction 11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.6.5 MedMira Recent Development 11.7 Trinity Biotech 11.7.1 Trinity Biotech Company Details 11.7.2 Trinity Biotech Business Overview 11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction 11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.7.5 Trinity Biotech Recent Development 11.8 Sekisui Diagnostics 11.8.1 Sekisui Diagnostics Company Details 11.8.2 Sekisui Diagnostics Business Overview 11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction 11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.8.5 Sekisui Diagnostics Recent Development 11.9 OraSure Technologies 11.9.1 OraSure Technologies Company Details 11.9.2 OraSure Technologies Business Overview 11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction 11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.9.5 OraSure Technologies Recent Development 11.10 Quidel 11.10.1 Quidel Company Details 11.10.2 Quidel Business Overview 11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction 11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) 11.10.5 Quidel Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of HIV POC Table 3. Key Players of Clostridium Difficile POC Table 4. Key Players of HBV POC Table 5. Key Players of Respiratory Syncytial Virus POC Table 6. Key Players of HPV POC Table 7. Key Players of Influenza/Flu POC Table 8. Key Players of HCV POC Table 9. Key Players of MRSA POC Table 10. Key Players of TB and Drug-Resistant TB POC Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million) Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2016-2021) Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2022-2027) Table 17. Point-of-care Infectious Disease Diagnostics Market Trends Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million) Table 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2016-2021) Table 23. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2020) Table 24. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2020 Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021) Table 26. Key Players Headquarters and Area Served Table 27. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service Table 28. Date of Enter into Point-of-care Infectious Disease Diagnostics Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021) Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million) Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2016-2021) Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 41. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 42. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 43. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 44. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 45. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 46. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 47. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 48. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 49. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 50. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 51. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 52. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 53. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 54. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million) Table 55. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million) Table 56. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 57. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 58. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 59. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 60. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 61. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 62. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million) Table 63. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million) Table 64. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million) Table 65. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million) Table 66. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million) Table 67. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million) Table 68. Thermo Fisher Scientific Company Details Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product Table 71. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 72. Thermo Fisher Scientific Recent Development Table 73. Abbott Company Details Table 74. Abbott Business Overview Table 75. Abbott Point-of-care Infectious Disease Diagnostics Product Table 76. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 77. Abbott Recent Development Table 78. Calypte Biomedical Company Details Table 79. Calypte Biomedical Business Overview Table 80. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product Table 81. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 82. Calypte Biomedical Recent Development Table 83. Chembio Diagnostic Systems Company Details Table 84. Chembio Diagnostic Systems Business Overview Table 85. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product Table 86. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 87. Chembio Diagnostic Systems Recent Development Table 88. Meridian Bioscience Company Details Table 89. Meridian Bioscience Business Overview Table 90. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product Table 91. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 92. Meridian Bioscience Recent Development Table 93. MedMira Company Details Table 94. MedMira Business Overview Table 95. MedMira Point-of-care Infectious Disease Diagnostics Product Table 96. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 97. MedMira Recent Development Table 98. Trinity Biotech Company Details Table 99. Trinity Biotech Business Overview Table 100. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product Table 101. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 102. Trinity Biotech Recent Development Table 103. Sekisui Diagnostics Company Details Table 104. Sekisui Diagnostics Business Overview Table 105. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 106. Sekisui Diagnostics Recent Development Table 107. OraSure Technologies Company Details Table 108. OraSure Technologies Business Overview Table 109. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product Table 110. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 111. OraSure Technologies Recent Development Table 112. Quidel Company Details Table 113. Quidel Business Overview Table 114. Quidel Point-of-care Infectious Disease Diagnostics Product Table 115. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2016-2021) & (US$ Million) Table 116. Quidel Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2020 VS 2027 Figure 2. HIV POC Features Figure 3. Clostridium Difficile POC Features Figure 4. HBV POC Features Figure 5. Respiratory Syncytial Virus POC Features Figure 6. HPV POC Features Figure 7. Influenza/Flu POC Features Figure 8. HCV POC Features Figure 9. MRSA POC Features Figure 10. TB and Drug-Resistant TB POC Features Figure 11. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2020 VS 2027 Figure 12. Hospitals Case Studies Figure 13. Clinics Case Studies Figure 14. Home Case Studies Figure 15. Assisted Living Healthcare Facilities Case Studies Figure 16. Laboratories Case Studies Figure 17. Others Case Studies Figure 18. Point-of-care Infectious Disease Diagnostics Report Years Considered Figure 19. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 20. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2027 Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2022-2027) Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2020 Figure 24. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2020 Figure 25. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2020 Figure 26. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021) Figure 27. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027) Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. North America Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027) Figure 30. North America Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027) Figure 31. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027) Figure 32. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Europe Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027) Figure 36. Europe Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027) Figure 37. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027) Figure 38. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Nordic Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027) Figure 46. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027) Figure 47. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Region (2016-2027) Figure 48. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027) Figure 56. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027) Figure 57. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027) Figure 58. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Type (2016-2027) Figure 62. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Application (2016-2027) Figure 63. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Country (2016-2027) Figure 64. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 66. UAE Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 68. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 69. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 70. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 71. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 72. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 73. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 74. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 75. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 76. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Thermo Fisher Scientific Abbott Calypte Biomedical Chembio Diagnostic Systems Meridian Bioscience MedMira Trinity Biotech Sekisui Diagnostics OraSure Technologies Quidel